No Image
Polyclonal Antibodies
Anti-CHD2 Polyclonal Antibody for WB, ELISA - O14647
Item Number : CM0014021
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 211kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | CHD2 Rabbit pAb |
| Remarks/Alias | EEOC, DEE94, CHD2 |
| Species | Human |
| Gene ID (Human) | 1106 |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 1729-1828 of human CHD2 (NP_001262.3) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human |
| SWISS | O14647 |
| Protein Weight | 211kDa |
| Shipping | Ice bag |
Biological Background: CHD2 Function and Localization
- CHD2, also known as Chromo domain-containing protein 2, is an ATP-dependent chromatin remodeling factor that regulates gene expression by altering nucleosome positioning.
- It specifically binds to promoter regions of target genes and promotes deposition of the histone variant H3.3, facilitating chromatin remodeling.
- CHD2 plays a critical role in myogenesis by interacting with MYOD1 at myogenic regulatory sequences, mediating H3.3 incorporation prior to myogenic gene activation.
- The protein contains chromodomains, an ATPase/helicase domain, and a DNA-binding domain, characteristic of the CHD family of chromatin remodelers.
- Subcellular localization is predominantly nuclear, consistent with its function in chromatin dynamics and transcriptional regulation.
- Keywords indicate involvement in transcription regulation, myogenesis, and alternative splicing, with associations to disease variants linked to epilepsy.
Experimental Guidance and Technical Tips
- The immunogen corresponds to amino acids 1729-1828 of human CHD2, a region predicted to generate an epitope-specific response; consider using the immunizing peptide for blocking or specificity controls in WB to confirm target recognition.
- For Western blot, the expected protein weight is approximately 211kDa; use appropriate gel conditions and transfer protocols for high-molecular-weight proteins.
- Validate antibody reactivity in human cell lines or tissues known to express CHD2, and include positive and negative controls to confirm performance.
- For ELISA applications, optimize coating and detection conditions using recombinant CHD2 protein or peptide as standard.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides IVD manufacturers, research laboratories, and diagnostic developers with comprehensive access to raw materials, technical services, and consulting—from concept to clinic. This anti-CHD2 polyclonal antibody supports chromatin biology and transcriptional regulation research, and we offer customized sourcing of validated antibody pairs, bulk ancillary reagents, and hard-to-find targets to streamline your assay development pipelines.
Product Datasheet
Anti-CHD2 Polyclonal Antibody for WB, ELISA - O14647
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!